Tempero Bio was created in 2020 by the venture firm Aditum Bio to advance the clinical development of a portfolio of potent, orally available metabotropic glutamate receptor 5 (mGluR5) NAMs, including ...
... of inhibitory ones, you can kind of know that NMDA, which is actually a glutamate receptor — it’s one of the two glutamate receptors and glutamate is the most common excitatory neuron in the brain.